top of page
About Us


Curespec is ushering in a new era of hope for chronic kidney disease (CKD) and hypertensive patients with Nephrospec™, our cutting-edge technology.

We stand as pioneers, offering a life-extending treatment that revitalizes kidneys, delays the need for dialysis, and lowers blood pressure, all while making significant cost savings for healthcare systems.

Our Product

Nephrospec™ is a safe, non-invasive low intensity electro-Hydraulic Acoustic Therapy device for the treatment of CKD and hypertension. 

Our patented technology promotes new blood vessel formation and restores damaged tissue function while saving up to 80% of the costs associated with dialysis.


Nephrospec™ by Curespec:

A complementary solution to optimize medical care for CKD and     hypertension

Improvement of kidney function within a few weeks 

Delayed onset of outpatient treatment for dialysis



Pre treatment

ARAS Kidney


Post Shockwave treatment

Curespec uses shockwave technology to produce a neovascularization affect on the kidneys.


Our Team

Our Team

Avner Spector_edited.jpg

Avner Spector

Founder, Active Chairman

Mr. Spector has over 30 years experience in the international Medtech industry, having held top R&D management positions in medical instrument companies in Israel and the US. He holds a B.Sc. Degree in Mechanical Engineering from Ben-Gurion-University of the Negev, Israel.

  • Grey LinkedIn Icon
rotem k_edited.jpg

Rotem Kaynan


Mr. Kaynan is a Biomedical Engineer, 2005 Technion – Israel Institute of Technology. More than 15 years of experience in Medical Devices, leading teams of clinical applications, sales & product management.

  • Grey LinkedIn Icon

Sandra Morgan

Executive Advisor

Ms.  Morgan has over  32 years in healthcare with Fortune 100 companies including HCA Healthcare and Pfizer. In the past she was an executive at HCA Healthcare responsible for business growth through physicians and service lines. In her last role at Pfizer, Sandra led the US managed care team responsible for achieving formulary status for Pfizer’s portfolio.

  • Grey LinkedIn Icon

Alex Slutzker

VP Clinical, Cofounder

Dr. Slutzker (Ph.D) has 10 years of experience in the clinical diagnostics and medical device fields. He holds a doctorate in the fields of Molecular biology, biochemistry and microbiology from the Ben-Gurion-University of the Negev, Israel

  • Grey LinkedIn Icon

Hagay Spector

R&D Director

Mr. Spector is an Electronics Engineer, (from 2009, HIT- Holon Institute of Technology). His major expertise is Product Development in all of its layers with wide knowledge in Shockwave systems and X-ray Vision. 

  • Grey LinkedIn Icon
yael shpilman.jpg

Yael Spielmann

RA Manager

Ms. Spielmann has over 17 years of experience in the medical device industry, serving as a Regulatory Affairs expert, developing regulatory strategies and compiling submissions to regulatory bodies worldwide.

  • Grey LinkedIn Icon

Advisory Board


Lilach O. Lerman, MD, PhD

The Arthur M. and Gladys D. Gray Professor in Honor of Dr. Howard A. Andersen Professor of Medicine and Physiology Director, Reno- Vascular Research Laboratory Division of Nephrology and Hypertension Mayo Clinic

  • Grey LinkedIn Icon

Amir Lerman, M.D.

Barbara Woodward Lips Professor 

Associate Chair, Cardiovascular  Medicine Director - Cardiovascular Research Center Consultant, Department of Cardiovascular Medicine Mayo Clinic

  • Grey LinkedIn Icon
Contact Us

Contact Us

Thanks for submitting!

  • Instagram
  • Facebook
  • LinkedIn
bottom of page